Leading Provider of B2B Data & Analytics Considers Expansion into the U.S. Provider Market

Leading Provider of B2B Data & Analytics Considers Expansion into the U.S. Provider Market

Christine O'Connell • June 18, 2021
Christine O'Connell • June 18, 2021

Share

Client and project overview

  • Our client, a leading provider of B2B data and analytics solutions to a variety of industries, including the healthcare payer market, was considering expansion into the U.S. provider market. They asked us to conduct a full market assessment to ensure they were making the right investment decision.


Key questions

  • What are the key features of the existing healthcare analytics market in the U.S., including the competitive landscape, market size, and workflow mapping?
  • How are these features likely to evolve in the future?
  • How are providers addressing each of the analytic needs (e.g., homegrown solutions or third-party solutions)?


Our Methodology

  • We conducted detailed primary research, leveraging market experts such as associations, analytics vendors and healthcare professionals, supplementing the insight with secondary research from reports
  • A subject-matter expert was engaged to support the interpretation of insights being generated through primary research, in addition to facilitating client discussions around implications and next steps


Results

  • Our study found that U.S. healthcare providers are taking on more clinical and financial risk as payment shifts from fee-for-service to risk-adjusted models, driving spend on analytics solutions that improve patient care, minimize cost and help quantify and measure risk
  • Current spend on healthcare analytics is forecast to grow at 35% CAGR in the near term, with addressable demand four times that of current spend
  • The vendor landscape is highly fragmented and comprised of infrastructure providers as well as pure-play analytics vendors

Read More

Will Barden Named Among The Consulting Report’s Top 25 Strategy Leaders of 2025
By Will Barden December 11, 2025
Will Barden, Partner, has been named among "The Consulting Report's" Top 25 Strategy Leaders of 2025. Click here to read more about the award.
Investing in Pharma Technology: A Healthcare Breakfast Discussion
By Rob Larson & Jordan Abrams December 8, 2025
In partnership with Raymond James and Farragut Square Group, Grant Thornton Stax recently hosted a breakfast event to share our investment analysis of the Pharma Technology market.
Miriam El-Baz & Connor Novy Honored as Consulting Magazine Women Leaders
December 2, 2025
Miriam El-Baz and Connor Novy were recognized at the Consulting Magazine Women Leaders awards to highlight the outstanding contributions made by women in consulting. Read more.
Featured in Financier Worldwide—Accelerating value in PE carve-outs: strategy and execution
By Phil Dunne & Peter Rodrigues-Renon November 11, 2025
Financier Worldwide discusses strategy & execution for accelerating value in carve-outs with Phil Dunne and Peter Rodrigues-Renon at Stax, including Gerard Nichol at Grant Thornton. Read more.
Key Considerations for Investors Exploring the Automotive Retail Tech Value Chain
By Sameer Tejani & Max Massaro November 6, 2025
Investment focus in automotive technology continues to broaden beyond OEMs to the core service ecosystem. Read what Sameer Tejani and Max Massaro see in the market.
Grant Thornton Stax Provides Sell-Side Support to SteelEye on its Merger With FundApps​
November 3, 2025
Grant Thornton Stax supported SteelEye, a leading trade and communications surveillance and data analytics platform, on its recent merger with FundApps. Read about the deal here.
Show More